Abstract
Aim: Acalculous cholecystitis (AAC) accounts for only 5-10% of cholecystitis cases, primarily studied in intensive care units (ICU) patients. The aim of this study to identify risk factors and clinical presentation of AAC in non-ICU patients. Material and methods: We conducted a literature review using PubMed MeshTerms “acalculous cholecystitis” and searched our institution’s database (2018-2022) for “cholecystitis” and “acalculous cholecystitis,” including patients with histopathological findings. Results: 23 patients met the inclusion criteria. based on histopathology report and diagnosis. The most common co-morbidities were cardiovascular and metabolic syndrome. Abdominal pain was the predominant complaint. Ten patients (50%) presented with elevated CRP, bilirubin, and leukocytosis. No mortality was reported at 30 days. Conclusion: AAC in outpatients is not associated with high mortality, unlike in ICU settings. However, it is more frequent in polymorbid patients with cardiovascular risk factors.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call